Azar: FDA to expedite review of Pfizer, Moderna
vaccines
In an interview discussing COVID-19 vaccine candidates, HHS
Secretary Alex Azar said the FDA would act speedily and would clear "any
unnecessary bureaucratic barriers" in order for vaccines from Moderna and
from Pfizer and BioNTech to reach the public. "We will independently call
those balls and strikes on the data and evidence, but we're going to do so as
quickly as possible, consistent with just making sure the science, the evidence
and the law support authorization," Azar added.
Full Story: The Hill (11/16)
No comments:
Post a Comment